BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 8984839)

  • 21. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
    Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
    Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
    Jones AS; Fish B; Fenton JE; Husband DJ
    Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results from 215 patients with laryngeal carcinoma treated with sole radiotherapy or with a combination of radiotherapy and operation (author's transl)].
    Glanzmann C; Horst W; Grossenbacher R; Fisch U
    Strahlentherapie; 1979 Jul; 155(7):451-6. PubMed ID: 494347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
    Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage surgery after radiation failure in squamous cell carcinoma of the larynx.
    Mercante G; Bacciu A; Banchini L; Moretto E; Oretti G; Ferri T
    B-ENT; 2005; 1(3):107-11. PubMed ID: 16255494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
    Schrijvers ML; van Riel EL; Langendijk JA; Dikkers FG; Schuuring E; van der Wal JE; van der Laan BF
    Head Neck; 2009 Jun; 31(6):759-64. PubMed ID: 19260127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surgical management and preservation of laryngeal function for senile patients with advanced laryngeal carcinoma].
    Zhang DG; Zhang HB; Luan XY; Pan XL; Xie G
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):379-81. PubMed ID: 17892137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy.
    Goleń M; Składowski K; Maciejewski B
    Neoplasma; 1999; 46(1):66-71. PubMed ID: 10355537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer.
    Holsinger FC; Funk E; Roberts DB; Diaz EM
    Head Neck; 2006 Sep; 28(9):779-84. PubMed ID: 16637055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical analysis of 57 patients with poorly differentiated carcinomas of the supraglottic larynx].
    Liu WS; Tang PZ; Qi YF; Xu ZG; Li ZJ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Sep; 39(9):562-5. PubMed ID: 15606009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma.
    Lo SM; Venkatesan V; Matthews TW; Rogers J
    J Otolaryngol; 1998 Oct; 27(5):247-51. PubMed ID: 9800621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oncologic surgery of the larynx after failure of radiotherapy].
    Pinilla M; González FM; Górriz C; Arellano B; Vicente J; Trinidad A
    Acta Otorrinolaringol Esp; 1998; 49(8):633-6. PubMed ID: 9951083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radical radiotherapy for T3 laryngeal cancers.
    Uno T; Itami J; Kotaka K; Toriyama M
    Strahlenther Onkol; 1996 Aug; 172(8):422-6. PubMed ID: 8765344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.